• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Orexigen Therapeutics Inc

+ Add to Watchlist

OREX:US

4.9700 USD 0.0200 0.40%

As of 20:10:00 ET on 08/01/2014.

Snapshot for Orexigen Therapeutics Inc (OREX)

Open: 5.0300 Day's Range: 4.8600 - 5.1400 Volume: 2,334,212
Previous Close: 4.9900 52wk Range: 4.5950 - 7.8200 1-Yr Rtn: -34.52%

Stock Chart for OREX

No chart data available.
  • OREX:US 4.9700
  • 1D
  • 1M
  • 1Y
4.9900
Interactive OREX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OREX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8200
Est. EPS (USD) (12/2014) -0.1060
Est. PEG Ratio -
Market Cap (M USD) 578.15
Shares Outstanding (M) 116.33
30 Day Average Volume 2,719,738
Price/Book (mrq) 26.6049
Price/Sale (ttm) 146.3106
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OREX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OREX

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for OREX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil